Skip Navigation LinksHome > September 2014 - Volume 29 - Issue 5 > Efficacy of once-daily extended release quetiapine fumarate...
International Clinical Psychopharmacology:
doi: 10.1097/YIC.0000000000000026
Original Articles

Efficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorder

Montgomery, Stuart A.a; Locklear, Julie C.b; Svedsäter, Henrikc; Eriksson, Hansc

Collapse Box


This study is a pooled, post-hoc analysis evaluating once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder (GAD). Three previously reported positive, 8-week, randomized, double-blind, placebo-controlled studies evaluated quetiapine XR therapy (50, 150, 300 mg/day) in patients with GAD [Hamilton Anxiety Rating Scale (HAM-A) total score≥20]. Patients were stratified by baseline severity: HAM-A total score ≥22, ≥24, <26, ≥26, ≥28. We report HAM-A total score change, response (≥50% reduction in HAM-A total score), and remission (HAM-A total score≤7 and ≤9). Quetiapine XR significantly improved HAM-A total scores compared with placebo at Weeks 1 and 8 in the HAM-A ≥22, ≥24, and ≥26 cohorts (all doses), at Week 1 (all doses) and Week 8 (quetiapine XR 150 mg/day) in the <26 cohort, and at Week 1 (all doses) and Week 8 (quetiapine XR 50 and 150 mg/day) in the HAM-A≥28 group (P<0.05). Week 8 effect sizes for 50, 150, and 300 mg/day were as follows: 0.29, 0.47, 0.17 (HAM-A≥22); 0.35, 0.55, 0.22 (HAM-A≥24); 0.18, 0.32, 0.10 (HAM-A<26); 0.41, 0.59, 0.24 (HAM-A≥26); 0.60, 0.64, 0.22 (HAM-A≥28), respectively. Acute quetiapine XR monotherapy significantly improves anxiety compared with placebo in patients with moderate or severe GAD, with symptom improvements seen as early as Week 1.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.